Extravasation of macromolecules and possible trapping of transforming growth factor-beta in venous ulceration.
The pathogenesis of venous ulceration is thought to involve formation of pericapillary fibrin cuffs as a result of venous hypertension, and a recent hypothesis suggests that extravasated plasma proteins may bind or trap growth factors. We have compared the tissue distribution of fibrin cuffs, plasma proteins, procollagen, and transforming growth factors (TGF-beta 1 and TGF-beta 2) within venous ulcers and normally healing graft donor sites. In venous ulcers, the papillary dermis and the ulcer bed contained convoluted capillaries with phosphotungstic acid haematoxylin-positive pericapillary fibrin cuffs. By immunohistochemical staining, the cuffs were positive for actin, and contained massively redundant lamellae of basement membrane material which stained positive for type IV collagen. Extravasated factor XIIIa and alpha 2-macroglobulin were present within the fibrin cuffs. Increased numbers of type I procollagen positive fibroblasts, and increased TGF-beta 1 immunoreactivity were present within the fibrin cuffs, but not in the provisional matrix in the ulcer bed around the cuffs. In contrast, in normally healing graft donor sites, tortuous capillaries and fibrin cuffs were absent, factor XIIIa and alpha 1-macroglobulin were restricted to the lumina of vessels, and procollagen and TGF-beta immunoreactivity were present within the granulation tissue and adjacent dermal matrix at the wound margin. These observations suggest that growth factors critical in wound healing, such as TGF-beta, are present within venous ulcers, but are abnormally distributed. Their distribution within fibrin cuffs and co-localization with extravasated plasma proteins, particularly alpha 2-macroglobulin, which is a recognized scavenger molecule for TGF-beta and other growth factors, provides evidence for a possible 'trapping' of growth factors in venous ulcers.
Higley
H R
HR
Celtrix Pharmaceuticals, Santa Clara, CA 95054, USA.
Ksander
G A
GA
Gerhardt
C O
CO
Falanga
V
V
D001798:Blood Proteins / Q000378:metabolism*; D002196:Capillaries / Q000473:pathology; D003094:Collagen / Q000032:analysis; D005337:Fibrin / Q000032:analysis; D006801:Humans; D007150:Immunohistochemistry; D046911:Macromolecular Substances; D011347:Procollagen / Q000032:analysis; D012867:Skin / Q000737:chemistry; D016212:Transforming Growth Factor beta / Q000032:analysis / Q000378:metabolism*; D011503:Transglutaminases / Q000032:analysis; D014647:Varicose Ulcer / Q000378:metabolism* / Q000473:pathology; D000511:alpha-Macroglobulins / Q000032:analysis
D001798:Blood Proteins; D046911:Macromolecular Substances; D011347:Procollagen; D016212:Transforming Growth Factor beta; D000511:alpha-Macroglobulins; D005337:Fibrin; D003094:Collagen; D011503:Transglutaminases